HIV-associated neurocognitive disorder
Conditions
Interventions
None listed
Sponsors
AIDS Clinical Center , National Center for Global Health and Medicine
National Kyushu Medical Center Ehime University Hospital Kawasaki Medical School Hospital Niigata City General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) HIV-infected patients (2) older than 20 years old (3) Japanese (4) Written informed consent
Exclusion criteria
Exclusion criteria: Active AIDS-defining disease. Congenital developmental retardation Definitive diagnosis of following diseases; Mental disorder, such as major depressive disorder, schizophrenia. Alzheimer's disease, Frontotemporallobar degeneration, Lewy-body disease, Vascular disease, Traumatic brain injury, Prion disease, Parkinson's disease, Huntington's disease. Another functional disorder (Epilepsy) Illegal substance use Severe alcoholism Endocrine disorder (hypothyroidism, Wernicke encephalopathy, Vitamin B12 deficiency) Current treatment or severe sequelae of CNS opportunistic infections Symptoms of a current, active infection a body temperature of >38.5 at the time of recruitment Experience of neuropsychiatric test within past 1 year Other inappropriate condition for neuropsychiatric test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The prevalence of HIV-associated neurocognitive disorder in Japan | — |
Secondary
| Measure | Time frame |
|---|---|
| The evaluation of risk and confounding factors for neuropsychiatric scores. | — |
Countries
Japan
Contacts
Public ContactEi Kinai
National Center for Global Health and Medicine AIDS Clinical Center
Outcome results
None listed